Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Imprinting genes have long been a stumbling block for unisexual reproduction in mammals, but scientists have now found a way past it.

Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 449.14% ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Intellia Therapeutics has dosed the first subject in the Phase III trial of NTLA-2002, to treat hereditary angioedema (HAE).